These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 523787)
21. Newer phenothiazines as anticonvulsants and monoamine oxidase inhibitors. Lata A; Satsangi RK; Srivastava VK Pharmazie; 1982 Aug; 37(8):549-51. PubMed ID: 7146060 [TBL] [Abstract][Full Text] [Related]
22. Synthesis of substituted anilino-(3-methoxy-4-(4-arylthiosemicarbazidocarbonylmethyleneoxy))benzylidenes: correlation between anticonvulsant activity and monoamine oxidase inhibitory and antihemolytic properties. Dwivedi C; Harbison RD; Ali B; Parmar SS J Pharm Sci; 1974 Jul; 63(7):1124-8. PubMed ID: 4854582 [No Abstract] [Full Text] [Related]
23. Inhibition of monoamine oxidase type A, but not type B, is an effective means of inducing anticonvulsant activity in the kindling model of epilepsy. Löscher W; Lehmann H; Teschendorf HJ; Traut M; Gross G J Pharmacol Exp Ther; 1999 Mar; 288(3):984-92. PubMed ID: 10027835 [TBL] [Abstract][Full Text] [Related]
28. Thiazolidinone congeners as central nervous system active agents. Tripathi M; Verma M; Gujrati VR; Palit G; Shanker K Arzneimittelforschung; 1993 Jun; 43(6):632-5. PubMed ID: 8352815 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase. Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Befani O; Turini P; Giovannini V; Mondovì B; Cirilli R; La Torre F J Med Chem; 2004 Apr; 47(8):2071-4. PubMed ID: 15056004 [TBL] [Abstract][Full Text] [Related]
30. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor. Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674 [TBL] [Abstract][Full Text] [Related]
31. Effects of some anxiogenic agents on rat brain monoamine oxidase (MAO) A and B inhibitory (tribulin) activity. Bhattacharya SK; Chakrabarti A; Sandler M; Glover V Indian J Exp Biol; 1996 Dec; 34(12):1190-3. PubMed ID: 9246908 [TBL] [Abstract][Full Text] [Related]
32. Anticonvulsant effects of phencynonate hydrochloride and other anticholinergic drugs in soman poisoning: neurochemical mechanisms. Wang YA; Zhou WX; Li JX; Liu YQ; Yue YJ; Zheng JQ; Liu KL; Ruan JX Life Sci; 2005 Nov; 78(2):210-23. PubMed ID: 16154160 [TBL] [Abstract][Full Text] [Related]
33. Lipophilicity plays a major role in modulating the inhibition of monoamine oxidase B by 7-substituted coumarins. Carotti A; Altomare C; Catto M; Gnerre C; Summo L; De Marco A; Rose S; Jenner P; Testa B Chem Biodivers; 2006 Feb; 3(2):134-49. PubMed ID: 17193252 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of monoamine oxidase activity by phenylpropanolamine, an anorectic agent. Yu PH Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):163-71. PubMed ID: 3961266 [TBL] [Abstract][Full Text] [Related]
35. Synthesis of 2-(N-arylcarboxamide)-3-substituted ethoxyindoles and their monoamine oxidase inhibitory and anticonvulsant activities. Gupta AK; Dwivedi C; Gupta TK; Parmar SS; Harbison RD J Pharm Sci; 1975 Jun; 64(6):1001-5. PubMed ID: 1133715 [TBL] [Abstract][Full Text] [Related]
36. Interrelationship between anticonvulsant and enzyme inhibitory properties of N-methyl-N-2-[1-(1-arylthiocarbamido)] cyclopentyl nitrobenzamides. Pandey BR; Singh SP; Brumleve SJ; Parmar SS Pharmacol Res Commun; 1981 Jan; 13(1):65-74. PubMed ID: 7220569 [No Abstract] [Full Text] [Related]
37. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro]. Gol'dina OA; Zagorevskiĭ VA; Lopatina KI; Sokolova TV; Gankina EM Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029 [TBL] [Abstract][Full Text] [Related]
38. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion. Gal S; Zheng H; Fridkin M; Youdim MB J Neurochem; 2005 Oct; 95(1):79-88. PubMed ID: 16181414 [TBL] [Abstract][Full Text] [Related]
39. E2011 a novel, selective and reversible inhibitor of monoamine oxidase type A. Kagaya T; Kajiwara A; Nagato S; Akasaka K; Kubota A J Pharmacol Exp Ther; 1996 Jul; 278(1):243-51. PubMed ID: 8764357 [TBL] [Abstract][Full Text] [Related]
40. [Effect of benzamide derivatives on convulsions induced by the toxic action of oxygen in rats]. Gol'dina OA; Tepliakov VG; Demurov EA; Koloskov IuB; Zagorevskiĭ VA Biull Eksp Biol Med; 1987 Oct; 104(10):469-71. PubMed ID: 3676473 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]